BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33428259)

  • 41. Surgical Delay and Pathological Outcomes for Clinically Localized High-Risk Prostate Cancer.
    Xia L; Talwar R; Chelluri RR; Guzzo TJ; Lee DJ
    JAMA Netw Open; 2020 Dec; 3(12):e2028320. PubMed ID: 33289846
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy.
    Kamat AM; Babaian K; Cheung MR; Naya Y; Huang SH; Kuban D; Babaian RJ
    J Urol; 2003 Nov; 170(5):1860-3. PubMed ID: 14532793
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radical prostatectomy in high-risk prostate cancer: incidence of specimen-confined disease (pT2-pT3a N0R0) and outcomes.
    Mearini L; Nunzi E; Bini V; Lepri L; Bruno R; Porena M
    Urologia; 2014; 81(2):125-32. PubMed ID: 24474543
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prostate carcinoma with positive margins at radical prostatectomy: role of tumour zonal origin in biochemical recurrence.
    O'Neil LM; Walsh S; Cohen RJ; Lee S
    BJU Int; 2015 Oct; 116 Suppl 3():42-8. PubMed ID: 26218868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/ml.
    Shariat SF; Abdel-Aziz KF; Roehrborn CG; Lotan Y
    Eur Urol; 2006 Feb; 49(2):293-302. PubMed ID: 16387412
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrative Genomic Analysis of Coincident Cancer Foci Implicates CTNNB1 and PTEN Alterations in Ductal Prostate Cancer.
    Gillard M; Lack J; Pontier A; Gandla D; Hatcher D; Sowalsky AG; Rodriguez-Nieves J; Vander Griend D; Paner G; VanderWeele D
    Eur Urol Focus; 2019 May; 5(3):433-442. PubMed ID: 29229583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-grade prostatic intraepithelial neoplasia is an independent predictor of outcome after radical prostatectomy.
    Pierorazio PM; Lambert SM; Matsukhani M; Sprenkle PC; McCann TR; Katz AE; Olsson CA; Benson MC; McKiernan JM
    BJU Int; 2007 Nov; 100(5):1066-70. PubMed ID: 17784880
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?
    Brausi M; Castagnetti G; Dotti A; De Luca G; Olmi R; Cesinaro AM
    J Urol; 2004 Sep; 172(3):906-8; discussion 908-9. PubMed ID: 15310995
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of robot-assisted and open retropubic radical prostatectomy for risk of biochemical progression in men with positive surgical margins.
    Shapiro EY; Scarberry K; Patel T; Bergman A; Ahn JJ; Sahi N; RoyChoudhury A; Deutch I; McKiernan JM; Benson MC; Badani KK
    J Endourol; 2014 Feb; 28(2):208-13. PubMed ID: 24044423
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary Gleason pattern in biopsy Gleason score 7 is predictive of adverse histopathological features and biochemical failure following radical prostatectomy.
    Berg KD; Røder MA; Brasso K; Vainer B; Iversen P
    Scand J Urol; 2014 Apr; 48(2):168-76. PubMed ID: 23889119
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of PSA velocity in predicting pathologic upgrade for Gleason 6 prostate cancer.
    Krane LS; Menon M; Kaul SA; Siddiqui SA; Wambi C; Peabody JO; Agarwal PK
    Urol Oncol; 2011; 29(4):372-7. PubMed ID: 19576796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: incidence and clinical implications.
    Rubin MA; de La Taille A; Bagiella E; Olsson CA; O'Toole KM
    Am J Surg Pathol; 1998 Jul; 22(7):840-8. PubMed ID: 9669346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic values of clinicopathological characteristics and survival outcomes in prostate infiltrating ductal carcinoma: a population-based study.
    Wu YP; Chen SH; Wang ST; Li XD; Cai H; Lin YZ; Xue XY; Wei Y; Zheng QS; Xu N
    Oncotarget; 2017 Apr; 8(17):29048-29055. PubMed ID: 28423709
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conformal radiotherapy for detectable PSA following radical prostatectomy: efficacy and predictive factors of recurrence.
    Delongchamps NB; Zerbib M; Mejean A; Rouach Y; Debre B; Peyromaure M
    Can J Urol; 2009 Oct; 16(5):4813-9. PubMed ID: 19796456
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Laparoscopic versus open radical prostatectomy in high prostate volume cases: impact on oncological and functional results.
    Alessandro S; Alessandro G; Susanna C; Michele I; Francesca DQ; Andrea F; Von Heland M; Vincenzo G; Stefano S
    Int Braz J Urol; 2016; 42(2):223-33. PubMed ID: 27256175
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A case of ductal carcinoma of the prostate after transurethral resection of prostate].
    Izumi K; Kanno H; Umemoto S; Hasumi H; Osada Y; Ota J; Tsuchiya F; Ogino I; Harada M
    Hinyokika Kiyo; 2007 May; 53(5):315-8. PubMed ID: 17561717
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Migration in last decade to high-risk prostate cancer after radical prostatectomy.
    Patard PM; Roumiguié M; Prudhomme T; Doumerc N; Thoulouzan M; Gamé X; de la Taille A; Rischmann P; Soulié M; Salomon L; Beauval JB
    Prog Urol; 2019 Jan; 29(1):29-35. PubMed ID: 30337057
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
    Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
    J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preoperative prostate health index and %p2PSA as the significant biomarkers of postoperative pathological outcomes of prostate cancer in Korean males: A prospective multi-institutional study.
    Park H; Lee SW; Song G; Kang TW; Jung JH; Chung HC; Kim SJ; Park JY; Shin TY; Kim JH
    Investig Clin Urol; 2020 Jan; 61(1):42-50. PubMed ID: 31942462
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The CPC Risk Calculator: A New App to Predict Prostate-specific Antigen Recurrence During Follow-up After Radical Prostatectomy.
    Røder MA; Berg KD; Loft MD; Thomsen FB; Ferrari M; Kurbegovic S; Rytgaard HC; Gruschy L; Brasso K; Gerds TA; Kjær A; Brooks JD; Iversen P
    Eur Urol Focus; 2018 Apr; 4(3):360-368. PubMed ID: 28753827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.